CETP and atherosclerosis: In this study, we tested alirocumab and/or evinacumab on top of atorvastatin as high-intensive lipid-lowering strategy to evaluate their effect on regression of pre-existent atherosclerosis in APOE*3-Leiden.CETP mice.